Cullinan Oncology Market Cap

Cullinan Oncology has a market cap or net worth of $717.90 million as of April 23, 2024. Its market cap has increased by 82.16% in one year.

Market Cap

717.90M

Enterprise Value

253.35M

1-Year Change

82.16%

Ranking

#2714

Market Cap Chart

Since the IPO on January 8, 2021, Cullinan Oncology's market cap has decreased from $829.45M to $717.90M, a decrease of -13.45%. That is a compound annual growth rate of -4.30%.

Market Cap History

Date	Market Cap	% Change
Apr 22, 2024	673.10M	-0.19%
Apr 19, 2024	674.40M	-13.29%
Apr 18, 2024	777.80M	1.01%
Apr 17, 2024	770.00M	3.23%
Apr 16, 2024	745.90M	4.66%
Apr 15, 2024	712.70M	-0.72%
Apr 12, 2024	717.90M	-4.04%
Apr 11, 2024	748.10M	1.82%
Apr 10, 2024	734.70M	0.18%
Apr 9, 2024	733.40M	0.18%
Apr 8, 2024	732.10M	-0.12%
Apr 5, 2024	733.00M	2.05%
Apr 4, 2024	718.30M	-3.02%
Apr 3, 2024	740.70M	1.23%
Apr 2, 2024	731.70M	-3.74%
Apr 1, 2024	760.10M	3.58%
Mar 28, 2024	733.80M	-3.90%
Mar 27, 2024	763.60M	5.67%
Mar 26, 2024	722.60M	-0.89%
Mar 25, 2024	729.10M	2.11%
Mar 22, 2024	714.00M	1.46%
Mar 21, 2024	703.70M	5.22%
Mar 20, 2024	668.80M	0.19%
Mar 19, 2024	667.50M	1.17%
Mar 18, 2024	659.80M	-3.82%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Pharming Group	692.32M
Longboard Pharmaceuticals	689.91M
Treace Medical Concepts	684.86M
Dianthus Therapeutics	683.78M
Silk Road Medical	680.07M
Y-mAbs Therapeutics	668.26M
Savara	664.49M
Immunome	654.83M

Market Cap Rankings